Legal Representation
Attorney
Christopher D. Olszyk, Jr.
USPTO Deadlines
Application History
36 events| Date | Code | Type | Description |
|---|---|---|---|
| Jan 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 24, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Jan 22, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Nov 15, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 15, 2024 | EXT5 | S | SOU EXTENSION 5 FILED |
| Jun 13, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Jun 13, 2024 | EXT4 | S | SOU EXTENSION 4 FILED |
| Jun 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 13, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 12, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 7, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Dec 5, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Dec 5, 2023 | EXT3 | S | SOU EXTENSION 3 FILED |
| Dec 5, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 9, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 6, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jun 6, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jun 6, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 16, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 14, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 14, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
| Nov 14, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 14, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Apr 19, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Apr 19, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Mar 30, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Mar 14, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 23, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 23, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 23, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 23, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 23, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 23, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 30, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 1, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Class 005
Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use
Class 010
Biopsy tests and devices, namely, medical instruments for use in performing blood-based testing and medical diagnostic apparatus for testing changes in biomarkers; cancer screening tests and devices, namely, medical devices for post-cancer treatment reoccurrence monitoring; medical diagnostic apparatus for testing patients' post-cancer treatment biomarkers
Class 042
Providing blood reagent sample testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of monitoring patients post-treatment for the probability of cancer reoccurrence
Class 044
Medical services, namely, providing blood testing and diagnostic services for others in the field of cancer testing, tumor testing, and screening for the purpose of monitoring patients post-treatment for the probability of cancer reoccurrence
Classification
International Classes
001
005
010
042
044
USPTO Documents
Loading USPTO documents...